Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Employee Long Term Incentive Plan

26 Jun 2014 08:00

RNS Number : 5071K
Toumaz Limited
26 June 2014
 



 

26 June 2014

 

Toumaz Limited

("Toumaz" or the "Company")

 

Toumaz Employee Long Term Incentive Plan ("LTIP")

 

Toumaz Limited (AIM: TMZ) announces that on 27 June 2014, the Company's employee benefit trust ("EBT"), together with participating employees and directors of the Company ("Participants"), will jointly subscribe for 31,361,243 new ordinary shares of 0.25p each in the capital of the Company ("Ordinary Shares") at a price of 0.25p per Ordinary Share ("JSOP Shares") pursuant to the implementation by the Company of the joint share ownership schedule to the LTIP ("JSOP").

 

Joint Share Ownership Plan

 

The JSOP has been put in place by the Company to enhance staff retention and provide a reward to Participants in the plan and effectively align their interests with those of all shareholders by providing a clear focus on maximising the long term value and profitability of the Company.

 

Under the JSOP, the JSOP Shares will be held by Participants jointly with the trustee of the EBT pursuant to the terms of joint ownership agreements between the EBT and each respective Participant.

 

Awards granted under the JSOP will vest on the third anniversary of their grant and value can be realised in respect of such awards from the date until the tenth anniversary of the date of grant. Participants will receive the full value of the share. The exercise price payable by Participants under the JSOP is 0.25p being equal to the nominal value of the Ordinary Shares.

 

All dividend and voting rights in the shares held by the JSOP have been waived, save that, in accordance with the terms of the JSOP, immediately prior to certain disposals of JSOP Shares these rights will be reinstated.

 

Awards under the Unapproved Scheme and Blocklisting Application

 

The Company also announces that on 27 June 2014 the Company will grant options over 6,916,767 Ordinary Shares under the Toumaz Limited Unapproved Share Option Scheme (2012 Rules) to employees of the Company and Former Chairman Prof Christofer Toumazou. Application has been made to the London Stock Exchange Plc for admission to AIM for a blocklisting of the Unapproved Shares which will on issue rank pari passu with the existing Ordinary Shares. The Unapproved Shares are expected to be blocklisted on 27 June 2014.

 

Admission of new Ordinary Shares

 

Application has today been made for the 31,361,243 JSOP Shares to be admitted to trading on AIM expected to be effective on 27 June 2014. The JSOP Shares on exercises will rank pari passu in all respects with the existing Ordinary Shares, other than as set out above.

 

Directors' Interests and Performance Criteria

 

The following Directors of the Company ("Directors") have been granted awards under the JSOP or unapproved scheme:

 

Name

June 2014 Grant

Existing Interest in JSOP Shares

Total Interest JSOP June 2014

Shareholding interest (incl JSOP Shares)

Anthony Sethill, CEO

8,200,000 (JSOP)

9,600,00

17,800,000

21,800,000

Jonathan Apps, CFO

6,000,000 (JSOP)

3,000,000

9,000,000

9,250,000

Christofer Toumazou, NED

2,000,000 (Unapproved)

6,000,000

6,000,000

23,059,895

 

Vesting of the JSOP and unapproved award issued to Directors are subject to the following performance criteria.  

 

Criteria 1

 

This performance criteria have been set such that the value of an Ordinary Share is required to outperform the FTSE All Share Index by 25 per cent over the course of the vesting period in order for 50 per cent of the award to vest and by 50 per cent in order for the balance of the awards to vest. Awards vest pro-rata between those two thresholds.

 

Criteria 2

 

50% of the award will be subject to the share price attaining a level of 15p for 90 days by 1 April 2019. The remaining 50% will be subject to the following. The value of an Ordinary Share is required to outperform the FTSE All Share Index by 25 per cent over the course of the vesting period in order for 25 per cent of the total award to vest and by 50 per cent, in order for the balance of the awards to vest. Awards vest pro-rata between those two thresholds.  This vesting will be not before 1 April 2017 and not after 1 April 2019.

 

Name

Role

June 2014 Grant

Criteria

Anthony Sethill

CEO

3,200,000

Criteria 1

Anthony Sethill

CEO

5,000,000

Criteria 2

Jonathan Apps

CFO

1,000,000

Criteria 1

Jonathan Apps

CFO

5,000,000

Criteria 2

Christofer Toumazou

NED

2,000,000

Criteria 1

 

Following the admission to trading of the New Shares, Toumaz will have a total issued share capital of 1,675,547,064 Ordinary Shares.

 

There are 80,863,044 Ordinary Shares held jointly by the Employee Benefit Trust and participants for the purposes of the Company's joint share ownership plan in relation to which all voting rights have been waived.

 

Therefore the total number of 1,594,684,020 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

 

 

For Further Enquiries:

 

Toumaz Limited

+44 (0) 207 391 0620

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

 

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0) 207 418 8900

Richard Kauffer/Daniel Harris

 

Instinctif Partners

+44 (0) 207 457 2020

Adrian Duffield/Kathy Gordon

 

About Toumaz (www.toumazltd.com)

 

Toumaz Limited is a pioneer in low cost ultra-low power, wireless semiconductor and software technologies for a wide range of markets including medical monitoring and internet connected consumer devices. The 2012 acquisition of Frontier Silicon brought operational scale and expertise together with a leadership position in digital and connected audio markets.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEUFSIFLSESM
Date   Source Headline
18th Sep 20157:00 amRNSBlock Listing Interim Review
19th Aug 20157:00 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf year trading update
13th Jul 20157:00 amRNSSt James's University Hospital trial
10th Jun 20157:00 amRNSCo-development agreement with Google
3rd Jun 201511:16 amRNSBoard change
29th May 20158:00 amRNSTotal Voting Rights
28th May 201510:20 amRNSResult of AGM
28th May 20157:00 amRNSTrading update
30th Apr 20158:00 amRNSTotal Voting Rights
21st Apr 20157:01 amRNSQueen Elizabeth Hospital trials SensiumVitals
21st Apr 20157:00 amRNSFull year results
1st Apr 201510:00 amRNSNotice of Results
19th Mar 20158:00 amRNSBlocklisting Interim Review
3rd Mar 20157:00 amRNSNorth American Healthcare distribution
29th Jan 20157:00 amRNSTrading update
28th Jan 20158:00 amRNSToumaz Employee Long Term Incentive Plan
28th Nov 20148:00 amRNSTotal Voting Rights
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSFrontier Silicon launches new digital radio module
4th Sep 20142:00 pmRNSFrontier Silicon supply agreement with Philips
27th Aug 201410:00 amRNSNotice of Results
19th Aug 20148:00 amRNSIssue of Equity
1st Aug 20147:00 amRNSTrading update
31st Jul 20148:00 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSSensium awarded Technology Strategy Board funding
30th Jun 20147:00 amRNSSouth African distribution for SensiumVitals
26th Jun 20148:00 amRNSEmployee Long Term Incentive Plan
23rd May 20144:34 pmRNSResult of AGM
23rd May 20147:00 amRNSTrading Update
20th May 20147:00 amRNSFrontier Silicon gains Digital Tick Mark approval
8th May 20147:00 amRNSMiddle East distribution for SensiumVitals®
28th Apr 201410:00 amRNSIssue of Equity
14th Apr 20147:00 amRNSNew radio chip and module preview
31st Mar 20147:00 amRNSFull year results
26th Mar 20147:00 amRNSSensiumVitals® expands distribution network
24th Mar 20147:00 amRNSPioneer selects Frontier Silicon's technology
7th Mar 20142:42 pmRNSNotice of Results
31st Jan 201410:00 amRNSTotal Voting Rights
17th Jan 20147:00 amRNSYear-end trading update
16th Dec 20137:00 amRNSFrontier Silicon extends Imagination partnership
25th Nov 201310:47 amRNSResult of EGM
25th Nov 20137:00 amRNSVenice module wins industry excellence award
13th Nov 20137:00 amRNSPatrick Hannon elected President of WorldDMB
7th Nov 20137:00 amRNSPlacing
15th Oct 20137:00 amRNSSensiumVitals: CE marking & UK hospital pilot
15th Oct 20137:00 amRNSDistribution agreement: first commercial US orders
23rd Sep 20137:00 amRNSHalf Year Results
9th Sep 20137:00 amRNSSpotify Connect Agreement
5th Sep 201311:20 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.